Cognitive ImpairmentNCT04033952
Strategy Training on Improving Executive Functions in Persons Following Acquired Brain Injury
A study testing Strategy Training in people with Cognitive Impairment and Stroke, run by Taipei Medical University at 3 sites in Taiwan.
Trial summary
About two-third individuals with acquired brain injury (ABI) experience cognitive impairments. Deficits in executive functions is one of the most prevalent cognitive impairments following ABI which result in decline of recovery and independence. Read more about this study
- Who is it for?
- Ages 20 years and older
- Conditions the study is for
- Cognitive Impairment, Stroke, Acquired Brain Injury
- What is being tested?
- Strategy Training
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 180 participants
- Where
- 3 sitesTaiwan
- Study dates
- 29 May 2018to 30 Sep 2024
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Ages 20 years and older
- Has a diagnosis of Acquired Brain Injury
- Understand Mandarin
- Has cognitive impairment
- Provide informed consent
Who cannot join
- Have severe aphasia
- Have a pre-stroke diagnosis of dementia, current major depressive disorder, substance use, or other psychiatric disorders that may impede them from continually participating in the study.
Trial locations and contacts
3 sites in 1 country.
Taiwan3 sites
National Taiwan University Hospital Bei-Hu branch
Taipei
National Taiwan University Hospital
Taipei
Taipei Medical University
Taipei
About this study
About two-third individuals with acquired brain injury (ABI) experience cognitive impairments. Deficits in executive functions is one of the most prevalent cognitive impairments following ABI which result in decline of recovery and independence. Lack of intervention shows evidence of immediate and long-term effect on executive function which is critical after returning to the community. The overall aim of this study is to examine the efficacy of strategy training intervention on executive functions and participation on community-dwelling people with ABI. Findings of the study will provide unequivocal evidence on the duration of effectiveness of strategy training and support the development and application of the program in rehabilitation practice.
Read the detailed description
The study will use a double-blinded, parallel-group randomized controlled trial to assess the efficacy of the strategy training intervention program in comparison to the control group. The investigators will recruit community-dwelling individuals with ABI in outpatient rehabilitation units and randomly assign them to the intervention group and the control group at a 1:1 ratio. Participants in the intervention group will receive strategy training 2 times per week for 10-15 sessions and participants in the control group will receive dose-matched non-active intervention carried out by a trained therapist. These efforts will allow the investigators to address the gap in rehabilitation research by demonstrating the effectiveness of strategy training on rebuilding and maintaining executive functions and lessening disability. This evidence will be important for rehabilitation practitioners to provide effective treatment to patients with cognitive impairments and will contribute to the improvement of quality of care of rehabilitation services.
- Conditions
- Cognitive Impairment, Stroke, Acquired Brain Injury
- Being tested
- Strategy Training
- Keywords
- Stroke, Cognition, Rehabilitation
- Medical subject headings
- Cognitive Dysfunction, Stroke, Brain Injuries
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Strategy TrainingBehavioural
This approach is different from traditional direct skill training, which emphasizes clinicians' responsibility on identifying their patients' challenges in performing activities and teaching patients task-specific problem-solving strategies. Strategy training, on the other hand, requires clinicians to take a role as a facilitator, guiding participants to learn through prompts and questions. In the training process, participants learn to develop their own problem-solving strategies and work through the problems they have, through which they can develop self-efficacy and confidence to manage participation challenges. Participants can also generalize the strategies they learn to other similar problems they encounter in daily life.
| Study group | Role | What they receive |
|---|---|---|
| Assigned Interventions | Experimental | The OPASS program will be delivered to the intervention group. The intervention protocols of the OPASS program were developed based on the strategy training guidelines developed by Skidmore et al. and based on the findings identified from the feasibility study. Trained research therapists will take the responsibility for delivering the intervention to participants. The program consists of four critical ingredients: self-selected goals, self-evaluation of performance, strategy development, and implementation, and therapeutic guided discovery. Receives: Behavioral: Strategy Training |
| Reflective listening | No intervention | Participants in the control group will receive dose-matched non-active intervention carried out by a trained research staff. The staff will use scripted questions to provoke participants to describe their experiences and feelings about their disease and their usual-care rehabilitation activities. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Stroop Test
Stroop test is a behavioral cognitive assessment tool. Participants will be asked to read out the ink color of the word as accurately and as soon as possible. The ink color of the word could be congruent or incongruent with the written color name. Each participant's time and error to complete the task will be calculated and recorded, in which a longer completion time and more error will indicate poorer outcome. Construct validity of the Stroop Test in the TBI population has been published.
Measured: Change from baseline to post-intervention within 1 week
Trail-Making Test (TMT A and B)
Trail-Making Test (TMT A and B) will be used to measure sustained attention, sequencing, mental flexibility, and visual tracking. TMT-A requires the individual to link in an ascending order a series of 25 numbered circles distributed randomly on a test paper as quickly as possible. TMT-B is similar, although it requires the individual to link switching alternatively between a set of numbers (1-13) and a set of letters (A-L) in an ascending order (1-A-2-B-3-C...). The Time and the amount of needed reminders to complete TMT A and B will be calculated, in which a longer completion time and more error will indicate poorer outcome. This instrument was validated in healthy people, patients with head injury, vascular disorders, and other diverse populations.
Measured: Change from baseline to post-intervention within 1 week
Montreal Cognitive Assessment (MoCA)
Montreal Cognitive Assessment (MoCA) is a clinician-reported measure consisting of cognition domains such as: visuospatial skills, executive functions, attention, concentration, calculation, language, abstraction, memory, and orientation. The summary score ranges from 0-30 points with higher scores indicating better cognitive function.
Measured: Change from baseline to post-intervention within 1 week
Secondary outcomes (59)
Activity Measure for Post-Acute Care (AMPAC) Outpatient Short Forms
The Activity Measure for Post-Acute Care (AMPAC) Outpatient Short Forms consists of three subscales that assesses three activity domains: basic mobility (18 items), daily activity (15 items), and applied cognitive (19 items). Each item asks the respondent to rate the difficulty to perform specified activities using a 4-point scale. The summary scores range 18-72, 15-60, 19-76 points respectively among three subscales. Higher score indicates better function of the specific domain. The summary scores for each subscale will be transformed into standardized scores on the t-score scale.
Measured: Change from baseline to post-intervention within 1 week
Activity Measure for Post-Acute Care (AMPAC) Outpatient Short Forms
The Activity Measure for Post-Acute Care (AMPAC) Outpatient Short Forms consists of three subscales that assesses three activity domains: basic mobility (18 items), daily activity (15 items), and applied cognitive (19 items). Each item asks the respondent to rate the difficulty to perform specified activities using a 4-point scale. The summary scores range 18-72, 15-60, 19-76 points respectively among three subscales. Higher score indicates better function of the specific domain. The summary scores for each subscale will be transformed into standardized scores on the t-score scale.
Measured: Change from post-intervention to 3 month follow-up, within 2 weeks
Activity Measure for Post-Acute Care (AMPAC) Outpatient Short Forms
The Activity Measure for Post-Acute Care (AMPAC) Outpatient Short Forms consists of three subscales that assesses three activity domains: basic mobility (18 items), daily activity (15 items), and applied cognitive (19 items). Each item asks the respondent to rate the difficulty to perform specified activities using a 4-point scale. The summary scores range 18-72, 15-60, 19-76 points respectively among three subscales. Higher score indicates better function of the specific domain. The summary scores for each subscale will be transformed into standardized scores on the t-score scale.
Measured: Change from 3 month to 6 month follow-up, within 2 weeks
Activity Measure for Post-Acute Care (AMPAC) Outpatient Short Forms
The Activity Measure for Post-Acute Care (AMPAC) Outpatient Short Forms consists of three subscales that assesses three activity domains: basic mobility (18 items), daily activity (15 items), and applied cognitive (19 items). Each item asks the respondent to rate the difficulty to perform specified activities using a 4-point scale. The summary scores range 18-72, 15-60, 19-76 points respectively among three subscales. Higher score indicates better function of the specific domain. The summary scores for each subscale will be transformed into standardized scores on the t-score scale.
Measured: Change from 6 month to 12 month follow-up, within 2 weeks
Healing encounters and attitudes list positive outlook questionnaire short form (HEAL-PO)
The Healing encounters and attitudes list positive outlook questionnaire short form (HEAL-PO) consists of 6 statements about perceived value on confidence and optimism in general. Each item is ranked on a 1 to 5 Likert-type scale. The summary score ranges from 6-30 points. Higher score indicates a more positive attitude on the participant. Scores are summed and then converted to T-score.
Measured: Change from baseline to post-intervention within 1 week
Healing encounters and attitudes list positive outlook questionnaire short form (HEAL-PO)
The Healing encounters and attitudes list positive outlook questionnaire short form (HEAL-PO) consists of 6 statements about perceived value on confidence and optimism in general. Each item is ranked on a 1 to 5 Likert-type scale. The summary score ranges from 6-30 points. Higher score indicates a more positive attitude on the participant. Scores are summed and then converted to T-score.
Measured: Change from post-intervention to 3 month follow-up, within 2 weeks
Healing encounters and attitudes list positive outlook questionnaire short form (HEAL-PO)
The Healing encounters and attitudes list positive outlook questionnaire short form (HEAL-PO) consists of 6 statements about perceived value on confidence and optimism in general. Each item is ranked on a 1 to 5 Likert-type scale. The summary score ranges from 6-30 points. Higher score indicates a more positive attitude on the participant. Scores are summed and then converted to T-score.
Measured: Change from 3 month to 6 month follow-up, within 2 weeks
Healing encounters and attitudes list positive outlook questionnaire short form (HEAL-PO)
The Healing encounters and attitudes list positive outlook questionnaire short form (HEAL-PO) consists of 6 statements about perceived value on confidence and optimism in general. Each item is ranked on a 1 to 5 Likert-type scale. The summary score ranges from 6-30 points. Higher score indicates a more positive attitude on the participant. Scores are summed and then converted to T-score.
Measured: Change from 6 month to 12 month follow-up, within 2 weeks
General Self Efficacy Scale (GSCS)
The General Self Efficacy Scale is a 10-item scale that is designed to assess optimistic self-beliefs to cope with a variety of difficult demands in life. Each item is rated using a 1-4 Likert scale, with higher score indicating greater self-efficacy. The summary score ranges from 10-40.
Measured: Change from baseline to post-intervention within 1 week
General Self Efficacy Scale (GSCS)
The General Self Efficacy Scale is a 10-item scale that is designed to assess optimistic self-beliefs to cope with a variety of difficult demands in life. Each item is rated using a 1-4 Likert scale, with higher score indicating greater self-efficacy. The summary score ranges from 10-40.
Measured: Change from post-intervention to 3 month follow-up, within 2 weeks
General Self Efficacy Scale (GSCS)
The General Self Efficacy Scale is a 10-item scale that is designed to assess optimistic self-beliefs to cope with a variety of difficult demands in life. Each item is rated using a 1-4 Likert scale, with higher score indicating greater self-efficacy. The summary score ranges from 10-40.
Measured: Change from 3 month to 6 month follow-up, within 2 weeks
General Self Efficacy Scale (GSCS)
The General Self Efficacy Scale is a 10-item scale that is designed to assess optimistic self-beliefs to cope with a variety of difficult demands in life. Each item is rated using a 1-4 Likert scale, with higher score indicating greater self-efficacy. The summary score ranges from 10-40.
Measured: Change from 6 month to 12 month follow-up, within 2 weeks
Canadian Occupational Performance Measure (COPM)
The Canadian Occupational Performance Measure inquires the client to identify important goals in their daily life and rate their importance, performance and satisfaction for each goal on a 10-point visual analog scale. The summary score ranges from 1-10 on each domain. Higher score indicates a more important, better performance and higher satisfaction on each determined goal. Scores are summed and then converted to T-score for analysis.
Measured: Change from baseline to post-intervention within 1 week
Canadian Occupational Performance Measure (COPM)
The Canadian Occupational Performance Measure inquires the client to identify important goals in their daily life and rate their importance, performance and satisfaction for each goal on a 10-point visual analog scale. The summary score ranges from 1-10 on each domain. Higher score indicates a more important, better performance and higher satisfaction on each determined goal. Scores are summed and then converted to T-score for analysis.
Measured: Change from post-intervention to 3 month follow-up, within 2 weeks
Canadian Occupational Performance Measure (COPM)
The Canadian Occupational Performance Measure inquires the client to identify important goals in their daily life and rate their importance, performance and satisfaction for each goal on a 10-point visual analog scale. The summary score ranges from 1-10 on each domain. Higher score indicates a more important, better performance and higher satisfaction on each determined goal. Scores are summed and then converted to T-score for analysis.
Measured: Change from 3 month to 6 month follow-up, within 2 weeks
Canadian Occupational Performance Measure (COPM)
The Canadian Occupational Performance Measure inquires the client to identify important goals in their daily life and rate their importance, performance and satisfaction for each goal on a 10-point visual analog scale. The summary score ranges from 1-10 on each domain. Higher score indicates a more important, better performance and higher satisfaction on each determined goal. Scores are summed and then converted to T-score for analysis.
Measured: Change from 6 month to 12 month follow-up, within 2 weeks
Stroop Test
Stroop test is a behavioral cognitive assessment tool. Participants will be asked to read out the ink color of the word as accurately and as soon as possible. The ink color of the word could be congruent or incongruent with the written color name. Each participant's time and error to complete the task will be calculated and recorded, in which a longer completion time and more error will indicate poorer outcome. Construct validity of the Stroop Test in the TBI population has been published.
Measured: Change from post-intervention to 3 month follow-up, within 2 weeks
Stroop Test
Stroop test is a behavioral cognitive assessment tool. Participants will be asked to read out the ink color of the word as accurately and as soon as possible. The ink color of the word could be congruent or incongruent with the written color name. Each participant's time and error to complete the task will be calculated and recorded, in which a longer completion time and more error will indicate poorer outcome. Construct validity of the Stroop Test in the TBI population has been published.
Measured: Change from 3 month to 6 month follow-up, within 2 weeks
Stroop Test
Stroop test is a behavioral cognitive assessment tool. Participants will be asked to read out the ink color of the word as accurately and as soon as possible. The ink color of the word could be congruent or incongruent with the written color name. Each participant's time and error to complete the task will be calculated and recorded, in which a longer completion time and more error will indicate poorer outcome. Construct validity of the Stroop Test in the TBI population has been published.
Measured: Change from 6 month to 12 month follow-up, within 2 weeks
Trail-Making Test (TMT A and B)
Trail-Making Test (TMT A and B) will be used to measure sustained attention, sequencing, mental flexibility, and visual tracking. TMT-A requires the individual to link in an ascending order a series of 25 numbered circles distributed randomly on a test paper as quickly as possible. TMT-B is similar, although it requires the individual to link switching alternatively between a set of numbers (1-13) and a set of letters (A-L) in an ascending order (1-A-2-B-3-C...). The Time and the amount of needed reminders to complete TMT A and B will be calculated, in which a longer completion time and more error will indicate poorer outcome. This instrument was validated in healthy people, patients with head injury, vascular disorders, and other diverse populations.
Measured: Change from post-intervention to 3 month follow-up, within 2 weeks
Trail-Making Test (TMT A and B)
Trail-Making Test (TMT A and B) will be used to measure sustained attention, sequencing, mental flexibility, and visual tracking. TMT-A requires the individual to link in an ascending order a series of 25 numbered circles distributed randomly on a test paper as quickly as possible. TMT-B is similar, although it requires the individual to link switching alternatively between a set of numbers (1-13) and a set of letters (A-L) in an ascending order (1-A-2-B-3-C...). The Time and the amount of needed reminders to complete TMT A and B will be calculated, in which a longer completion time and more error will indicate poorer outcome. This instrument was validated in healthy people, patients with head injury, vascular disorders, and other diverse populations.
Measured: Change from 3 month to 6 month follow-up, within 2 weeks
Trail-Making Test (TMT A and B)
Trail-Making Test (TMT A and B) will be used to measure sustained attention, sequencing, mental flexibility, and visual tracking. TMT-A requires the individual to link in an ascending order a series of 25 numbered circles distributed randomly on a test paper as quickly as possible. TMT-B is similar, although it requires the individual to link switching alternatively between a set of numbers (1-13) and a set of letters (A-L) in an ascending order (1-A-2-B-3-C...). The Time and the amount of needed reminders to complete TMT A and B will be calculated, in which a longer completion time and more error will indicate poorer outcome. This instrument was validated in healthy people, patients with head injury, vascular disorders, and other diverse populations.
Measured: Change from 6 month to 12 month follow-up, within 2 weeks
National Institutes of Health Stroke scale (NIHSS)
The National Institutes of Health Stroke scale (NIHSS) is a 15-item measurement designed to assess symptoms indicating severity of stroke by clinicians. Each item is rated 0-2 or 0-3 points according to the symptoms which are commonly seen after stroke . The summary score ranges from 0-42 with higher score indicating greater severity of stroke.
Measured: Change from baseline to post-intervention within 1 week
National Institutes of Health Stroke scale (NIHSS)
The National Institutes of Health Stroke scale (NIHSS) is a 15-item measurement designed to assess symptoms indicating severity of stroke by clinicians. Each item is rated 0-2 or 0-3 points according to the symptoms which are commonly seen after stroke . The summary score ranges from 0-42 with higher score indicating greater severity of stroke.
Measured: Change from post-intervention to 3 month follow-up, within 2 weeks
National Institutes of Health Stroke scale (NIHSS)
The National Institutes of Health Stroke scale (NIHSS) is a 15-item measurement designed to assess symptoms indicating severity of stroke by clinicians. Each item is rated 0-2 or 0-3 points according to the symptoms which are commonly seen after stroke . The summary score ranges from 0-42 with higher score indicating greater severity of stroke.
Measured: Change from 3 month to 6 month follow-up, within 2 weeks
National Institutes of Health Stroke scale (NIHSS)
The National Institutes of Health Stroke scale (NIHSS) is a 15-item measurement designed to assess symptoms indicating severity of stroke by clinicians. Each item is rated 0-2 or 0-3 points according to the symptoms which are commonly seen after stroke . The summary score ranges from 0-42 with higher score indicating greater severity of stroke.
Measured: Change from 6 month to 12 month follow-up, within 2 weeks
Rancho Los Amigos Scale-Revised (RLAS-R)
Rancho Los Amigos Scale-Revised (RLAS-R) is an ordinal scale which describes the cognitive and behavioral patterns found in brain injury patients as they recover from injury. The levels are assessed by clinicians and range from 1 to 10 with higher scores indicating better functioning on brain injury participants.
Measured: Change from baseline to post-intervention within 1 week
Rancho Los Amigos Scale-Revised (RLAS-R)
Rancho Los Amigos Scale-Revised (RLAS-R) is an ordinal scale which describes the cognitive and behavioral patterns found in brain injury patients as they recover from injury. The levels are assessed by clinicians and range from 1 to 10 with higher scores indicating better functioning on brain injury participants.
Measured: Change from post-intervention to 3 month follow-up, within 2 weeks
Rancho Los Amigos Scale-Revised (RLAS-R)
Rancho Los Amigos Scale-Revised (RLAS-R) is an ordinal scale which describes the cognitive and behavioral patterns found in brain injury patients as they recover from injury. The levels are assessed by clinicians and range from 1 to 10 with higher scores indicating better functioning on brain injury participants.
Measured: Change from 3 month to 6 month follow-up, within 2 weeks
Rancho Los Amigos Scale-Revised (RLAS-R)
Rancho Los Amigos Scale-Revised (RLAS-R) is an ordinal scale which describes the cognitive and behavioral patterns found in brain injury patients as they recover from injury. The levels are assessed by clinicians and range from 1 to 10 with higher scores indicating better functioning on brain injury participants.
Measured: Change from 6 month to 12 month follow-up, within 2 weeks
Modified Rankin Scale (mRS)
The modified Rankin Scale (mRS) is designed to measure the degree of disability after a stroke. Each participant is rated 0-6 point on an ordinal scale with higher score indicating greater disability after stroke.
Measured: Change from baseline to post-intervention within 1 week
Modified Rankin Scale (mRS)
The modified Rankin Scale (mRS) is designed to measure the degree of disability after a stroke. Each participant is rated 0-6 point on an ordinal scale with higher score indicating greater disability after stroke.
Measured: Change from post-intervention to 3 month follow-up, within 2 weeks
Modified Rankin Scale (mRS)
The modified Rankin Scale (mRS) is designed to measure the degree of disability after a stroke. Each participant is rated 0-6 point on an ordinal scale with higher score indicating greater disability after stroke.
Measured: Change from 3 month to 6 month follow-up, within 2 weeks
Modified Rankin Scale (mRS)
The modified Rankin Scale (mRS) is designed to measure the degree of disability after a stroke. Each participant is rated 0-6 point on an ordinal scale with higher score indicating greater disability after stroke.
Measured: Change from 6 month to 12 month follow-up, within 2 weeks
Euro-QoL-5-Dimension (EQ-5D)
The Euro-QoL-5-Dimension (EQ-5D) is used to assess participant's health related quality of life which consist of 5 ordinal scale items and 1 item with visual analog scale. Ordinal scales are rated 0-3 points with higher score indicating the pooer health-related quality of life. visual analog scale are rated by respondents reporting perceived health status with a grade ranging from 0 to 100 with higher score indicating the better health status).
Measured: Change from baseline to post-intervention within 1 week
Euro-QoL-5-Dimension (EQ-5D)
The Euro-QoL-5-Dimension (EQ-5D) is used to assess participant's health related quality of life which consist of 5 ordinal scale items and 1 item with visual analog scale. Ordinal scales are rated 0-3 points with higher score indicating the pooer health-related quality of life. visual analog scale are rated by respondents reporting perceived health status with a grade ranging from 0 to 100 with higher score indicating the better health status).
Measured: Change from post-intervention to 3 month follow-up, within 2 weeks
Euro-QoL-5-Dimension (EQ-5D)
The Euro-QoL-5-Dimension (EQ-5D) is used to assess participant's health related quality of life which consist of 5 ordinal scale items and 1 item with visual analog scale. Ordinal scales are rated 0-3 points with higher score indicating the pooer health-related quality of life. visual analog scale are rated by respondents reporting perceived health status with a grade ranging from 0 to 100 with higher score indicating the better health status).
Measured: Change from 3 month to 6 month follow-up, within 2 weeks
Euro-QoL-5-Dimension (EQ-5D)
The Euro-QoL-5-Dimension (EQ-5D) is used to assess participant's health related quality of life which consist of 5 ordinal scale items and 1 item with visual analog scale. Ordinal scales are rated 0-3 points with higher score indicating the pooer health-related quality of life. visual analog scale are rated by respondents reporting perceived health status with a grade ranging from 0 to 100 with higher score indicating the better health status).
Measured: Change from 6 month to 12 month follow-up, within 2 weeks
Qualitative data
Qualitative in-depth interviews with participants, caregivers, and therapists will be conducted following the intervention. In-depth interviews will be conducted by well-trained interviewers at the end of each participant's intervention. The research team will develop an interview guide consisting of a series of open-ended questions. All intervention sessions will be audio-recorded and transcribed verbatim. Observational data and notes from the therapists, assessors, and research team meetings will be collected and reviewed by the research team throughout the study.
Measured: After intervention, an average of 2 month
Participation Measure- 3 Domains, 4 Dimensions (PM-3D4D)
The PM-3D4D is a 19-item measure that was designed to evaluate three domains of participation: Productivity, Social, and Community. Respondents are asked to rate each item on four dimensions: (1) 'Diversity of participation' (yes [1] vs. no [0]); (2) 'Frequency'(5- and 7-point scales, from "never" to "everyday or almost everyday"); (3) 'Desire for change' (yes [1] vs. no[0]); and (4) 'Perceived difficulty' (4-point scale, from "very difficult" [1] to "not difficult at all" [4]). Each dimensional score of the PM-3D4D can be separately summed for each domain. Psychometric properties of the PM-3D4D were established in rehabilitation populations.
Measured: Change from baseline to post-intervention within 1 week
Participation Measure- 3 Domains, 4 Dimensions (PM-3D4D)
The PM-3D4D is a 19-item measure that was designed to evaluate three domains of participation: Productivity, Social, and Community. Respondents are asked to rate each item on four dimensions: (1) 'Diversity of participation' (yes [1] vs. no [0]); (2) 'Frequency'(5- and 7-point scales, from "never" to "everyday or almost everyday"); (3) 'Desire for change' (yes [1] vs. no[0]); and (4) 'Perceived difficulty' (4-point scale, from "very difficult" [1] to "not difficult at all" [4]). Each dimensional score of the PM-3D4D can be separately summed for each domain. Psychometric properties of the PM-3D4D were established in rehabilitation populations.
Measured: Change from post-intervention to 3 month follow-up, within 2 weeks
Participation Measure- 3 Domains, 4 Dimensions (PM-3D4D)
The PM-3D4D is a 19-item measure that was designed to evaluate three domains of participation: Productivity, Social, and Community. Respondents are asked to rate each item on four dimensions: (1) 'Diversity of participation' (yes [1] vs. no [0]); (2) 'Frequency'(5- and 7-point scales, from "never" to "everyday or almost everyday"); (3) 'Desire for change' (yes [1] vs. no[0]); and (4) 'Perceived difficulty' (4-point scale, from "very difficult" [1] to "not difficult at all" [4]). Each dimensional score of the PM-3D4D can be separately summed for each domain. Psychometric properties of the PM-3D4D were established in rehabilitation populations.
Measured: Change from 3 month to 6 month follow-up, within 2 weeks
Participation Measure- 3 Domains, 4 Dimensions (PM-3D4D)
The PM-3D4D is a 19-item measure that was designed to evaluate three domains of participation: Productivity, Social, and Community. Respondents are asked to rate each item on four dimensions: (1) 'Diversity of participation' (yes [1] vs. no [0]); (2) 'Frequency'(5- and 7-point scales, from "never" to "everyday or almost everyday"); (3) 'Desire for change' (yes [1] vs. no[0]); and (4) 'Perceived difficulty' (4-point scale, from "very difficult" [1] to "not difficult at all" [4]). Each dimensional score of the PM-3D4D can be separately summed for each domain. Psychometric properties of the PM-3D4D were established in rehabilitation populations.
Measured: Change from 6 month to 12 month follow-up, within 2 weeks
Resting-state functional Magnetic Resonance Imaging scan (rs-fMRI)
The Resting-state (rs-fMRI) scan will be administered by a 3T Siemens Magnetom Trio-Tim magnet scanner at National Yang-Ming University. Participants will be asked to keep their eyes closed, heads still, not falling sleep, and think nothing in particular. A T2*-weighted gradient-echo echo planar imaging (EPI) sequence will be employed with TR/TE/FA = 2000 ms/30 ms/90°, 185 time points, resolution: 3×3×3 mm3, 35 axial slides and 6 minutes total scan time. Each participant's relative activity time courses of the blood oxygenation level-dependent (BOLD) response will be collected for analysis.
Measured: Change from baseline to post-intervention within 1 week
Resting-state functional Magnetic Resonance Imaging scan (rs-fMRI)
The Resting-state (rs-fMRI) scan will be administered by a 3T Siemens Magnetom Trio-Tim magnet scanner at National Yang-Ming University. Participants will be asked to keep their eyes closed, heads still, not falling sleep, and think nothing in particular. A T2*-weighted gradient-echo echo planar imaging (EPI) sequence will be employed with TR/TE/FA = 2000 ms/30 ms/90°, 185 time points, resolution: 3×3×3 mm3, 35 axial slides and 6 minutes total scan time. Each participant's relative activity time courses of the blood oxygenation level-dependent (BOLD) response will be collected for analysis.
Measured: Change from post-intervention to 1 year follow-up, within 2 weeks
functional Magnetic Resonance Imaging scan with a Color Stroop task
The functional Magnetic Resonance Imaging scan with a Stroop task will be administered by a 3T Siemens Magnetom Trio-Tim magnet scanner at National Yang-Ming University. A segmented Stroop modified task programmed with E-Prime package will be administered. Participants will be asked to press the corresponding color of the word as accurately and as soon as possible during the task. The ink color of the word could be congruent or incongruent with the written color name. A total scan time is approximately 7 minutes. Specific regions of interest (ROIs), including prefrontal regions will be selected individually for each subject, using a combination of anatomical and functional criteria. The average beta values of the contrast between different levels of task difficulties in these ROIs will be extracted and analyzed.
Measured: Change from baseline to immediately post-intervention within 1 week
functional Magnetic Resonance Imaging scan with a Color Stroop task
The functional Magnetic Resonance Imaging scan with a Stroop task will be administered by a 3T Siemens Magnetom Trio-Tim magnet scanner at National Yang-Ming University. A segmented Stroop modified task programmed with E-Prime package will be administered. Participants will be asked to press the corresponding color of the word as accurately and as soon as possible during the task. The ink color of the word could be congruent or incongruent with the written color name. A total scan time is approximately 7 minutes. Specific regions of interest (ROIs), including prefrontal regions will be selected individually for each subject, using a combination of anatomical and functional criteria. The average beta values of the contrast between different levels of task difficulties in these ROIs will be extracted and analyzed.
Measured: Change from post-intervention to 1 year follow-up, within 2 weeks
functional Magnetic Resonance Imaging scan of anatomical structure
The functional Magnetic Resonance Imaging scan of anatomical structure will be administered by a 3T Siemens Magnetom Trio-Tim magnet scanner at National Yang-Ming University. Participants will be asked to keep their eyes closed, heads still, not falling sleep, and think nothing in particular. A high-resolution three-dimensional MPRAGE sequence will be used to obtain T1-weighted images with 1mm3 isotropic resolution with a scan time of approximately 4.5 min.
Measured: Change from baseline to post-intervention within 1 week
functional Magnetic Resonance Imaging scan of anatomical structure
The functional Magnetic Resonance Imaging scan of anatomical structure will be administered by a 3T Siemens Magnetom Trio-Tim magnet scanner at National Yang-Ming University. Participants will be asked to keep their eyes closed, heads still, not falling sleep, and think nothing in particular. A high-resolution three-dimensional MPRAGE sequence will be used to obtain T1-weighted images with 1mm3 isotropic resolution with a scan time of approximately 4.5 min.
Measured: Change from post-intervention to 1 year follow-up, within 2 weeks
functional Magnetic Resonance Imaging scan with a Emotion Stroop task
The functional Magnetic Resonance Imaging scan with a Stroop task will be administered by a 3T Siemens Magnetom Trio-Tim magnet scanner at National Yang-Ming University. A segmented Stroop modified task programmed with E-Prime package will be administered. Participants will be asked to press the corresponding emotion of the word as accurately and as soon as possible during the task. The word representing the emotion could be congruent or incongruent with the background facial expression. A total scan time is approximately 9.5 minutes. Specific regions of interest (ROIs), including prefrontal regions will be selected individually for each subject, using a combination of anatomical and functional criteria. The average beta values of the contrast between different levels of task difficulties in these ROIs will be extracted and analyzed.
Measured: Change from baseline to post-intervention within 1 week
functional Magnetic Resonance Imaging scan with a Emotion Stroop task
The functional Magnetic Resonance Imaging scan with a Stroop task will be administered by a 3T Siemens Magnetom Trio-Tim magnet scanner at National Yang-Ming University. A segmented Stroop modified task programmed with E-Prime package will be administered. Participants will be asked to press the corresponding emotion of the word as accurately and as soon as possible during the task. The word representing the emotion could be congruent or incongruent with the background facial expression. A total scan time is approximately 9.5 minutes. Specific regions of interest (ROIs), including prefrontal regions will be selected individually for each subject, using a combination of anatomical and functional criteria. The average beta values of the contrast between different levels of task difficulties in these ROIs will be extracted and analyzed.
Measured: Change from post-intervention to 1 year follow-up, within 2 weeks
Healing encounters and attitudes list patient-provider connection short form (HEAL-PPC)
The Patient-Provider Connection Short Form consists of 7 statements in which participants are asked to rate the degree to which they feel the therapist understands and respects them, and provides them with enough information. Each item is ranked on a 1 to 5 Likert-type scale. The total value of the scale ranges from 7 to 35 with a higher score reflecting more positive perspectives a patient had on the connection between patient and health provider. Scores are summed and then converted to T-score.
Measured: At the time of post-intervention within 1 week
Montreal Cognitive Assessment (MoCA)
Montreal Cognitive Assessment (MoCA) is a clinician-reported measure consisting of cognition domains such as: visuospatial skills, executive functions, attention, concentration, calculation, language, abstraction, memory, and orientation. The summary score ranges from 0-30 points with higher scores indicating better cognitive function.
Measured: Change from post-intervention to 3 month follow-up, within 2 weeks
Montreal Cognitive Assessment (MoCA)
Montreal Cognitive Assessment (MoCA) is a clinician-reported measure consisting of cognition domains such as: visuospatial skills, executive functions, attention, concentration, calculation, language, abstraction, memory, and orientation. The summary score ranges from 0-30 points with higher scores indicating better cognitive function.
Measured: Change from 3 month to 6 month follow-up, within 2 weeks
Montreal Cognitive Assessment (MoCA)
Montreal Cognitive Assessment (MoCA) is a clinician-reported measure consisting of cognition domains such as: visuospatial skills, executive functions, attention, concentration, calculation, language, abstraction, memory, and orientation. The summary score ranges from 0-30 points with higher scores indicating better cognitive function.
Measured: Change from 6 month to 12 month follow-up, within 2 weeks
Pittsburgh Rehabilitation Participation Scale
Pittsburgh Rehabilitation Participation Scale is assessed on a 6-point Likert-type scale reflecting the therapists observations of patient participation. The summary score is transformed to an average score for interpretation. The score ranges from 0-6 points with higher scores indicating better participation in each session.
Measured: During the procedure
Level of understanding of the intervention session
Level of understanding of the intervention session is rated by clinicians with a structured questionnaire developed by the research team. A 3 point ordinal scale is administered with a higher score indicating better level of understanding of the intervention session.The total value of the scale depends on the lessons the participant received, ranging from 1*amount of received lessons - 3*amount of received lessons. The score is adopted in the form of average score, ranging from 1 to 3 points.
Measured: During the procedure
Healing encounters and attitudes list treatment expectancy short form (HEAL-TE)
Healing encounters and attitudes list treatment expectancy short form is a 6-item self-rated measurement designed to assess the expectations of a participant about whether the treatment will be helpful. Each item will be scored in a 5-point Likert scale. The total value of the scale ranges from 5 to 30 with a higher score indicating higher expectation of the treatment. The score is adopted in the form of average score, ranging from 1 to 5 points.
Measured: baseline, pre-intervention
Client Satisfaction Questionnaire (CSQ)
Client Satisfaction Questionnaire is a 8 item questionnaire of 4-point Likert scale reflecting the satisfaction of the treatment. The score is adopted in the form of an average score ranging from 1 to 4 points with a higher score indicating higher satisfaction of the treatment.
Measured: At the time of post-intervention within 1 week
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Jul 2019
- Study start29 May 2018
- Primary completion31 Aug 2022
- Study completion30 Sep 2024 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Cognitive ImpairmentStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Investigator, Outcomes assessor
- Enrolment
- 180 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Taipei Medical University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Feng-Hang Chang, Taipei Medical University
- Investigators
- Feng-Hang Chang, Principal investigator, Taipei Medical University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04033952
- Sponsor's protocol ID
- N201905030
- Status last verified
- Apr 2024
- First submitted
- 24 Jul 2019
- Last updated
- 10 Apr 2024
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: The IPD is not planned to be shared.
Study at a glance
From the registry record, last updated by the sponsor on 10 Apr 2024. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Strategy Training on Improving Executive Functions in Persons Following Acquired Brain Injury
- ClinicalTrials.gov ID
- NCT04033952
- Acronym / sponsor ID
- N201905030
- Conditions
- Cognitive Impairment, Stroke, Acquired Brain Injury
- Keywords
- Stroke, Cognition, Rehabilitation
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 180 participants (estimated)
- Lead sponsor
- Taipei Medical UniversityUniversity, hospital or other
- Study start
- 29 May 2018 (actual)
- Primary completion
- 31 Aug 2022 (actual)
- Study completion
- 30 Sep 2024 (estimated)
- First posted
- 26 Jul 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
About two-third individuals with acquired brain injury (ABI) experience cognitive impairments. Deficits in executive functions is one of the most prevalent cognitive impairments following ABI which result in decline of recovery and independence. Lack of intervention shows evidence of immediate and long-term effect on executive function which is critical after returning to the community. The overall aim of this study is to examine the efficacy of strategy training intervention on executive functions and participation on community-dwelling people with ABI. Findings of the study will provide unequivocal evidence on the duration of effectiveness of strategy training and support the development and application of the program in rehabilitation practice.
Detailed description
The study will use a double-blinded, parallel-group randomized controlled trial to assess the efficacy of the strategy training intervention program in comparison to the control group. The investigators will recruit community-dwelling individuals with ABI in outpatient rehabilitation units and randomly assign them to the intervention group and the control group at a 1:1 ratio. Participants in the intervention group will receive strategy training 2 times per week for 10-15 sessions and participants in the control group will receive dose-matched non-active intervention carried out by a trained therapist. These efforts will allow the investigators to address the gap in rehabilitation research by demonstrating the effectiveness of strategy training on rebuilding and maintaining executive functions and lessening disability. This evidence will be important for rehabilitation practitioners to provide effective treatment to patients with cognitive impairments and will contribute to the improvement of quality of care of rehabilitation services.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Assigned Interventions | Experimental | Behavioral: Strategy TrainingThe OPASS program will be delivered to the intervention group. The intervention protocols of the OPASS program were developed based on the strategy training guidelines developed by Skidmore et al. and based on the findings identified from the feasibility study. Trained research therapists will take the responsibility for delivering the intervention to participants. The program consists of four critical ingredients: self-selected goals, self-evaluation of performance, strategy development, and implementation, and therapeutic guided discovery. |
| Reflective listening | No intervention | –Participants in the control group will receive dose-matched non-active intervention carried out by a trained research staff. The staff will use scripted questions to provoke participants to describe their experiences and feelings about their disease and their usual-care rehabilitation activities. |
Who may qualify
- Ages
- 20 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Ages 20 years and older
- Has a diagnosis of Acquired Brain Injury
- Understand Mandarin
- Has cognitive impairment
- Provide informed consent
Key exclusion criteria (2 listed)
- Have severe aphasia
- Have a pre-stroke diagnosis of dementia, current major depressive disorder, substance use, or other psychiatric disorders that may impede them from continually participating in the study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Strategy TrainingThis approach is different from traditional direct skill training, which emphasizes clinicians' responsibility on identifying their patients' challenges in performing activities and teaching patients task-specific problem-solving strategies. Strategy training, on the other hand, requires clinicians to take a role as a facilitator, guiding participants to learn through prompts and questions. In the training process, participants learn to develop their own problem-solving strategies and work through the problems they have, through which they can develop self-efficacy and confidence to manage participation challenges. Participants can also generalize the strategies they learn to other similar problems they encounter in daily life. | Behavioural | Assigned Interventions |
Primary outcome
Stroop Test
Time frame: Change from baseline to post-intervention within 1 week
Stroop test is a behavioral cognitive assessment tool. Participants will be asked to read out the ink color of the word as accurately and as soon as possible. The ink color of the word could be congruent or incongruent with the written color name. Each participant's time and error to complete the task will be calculated and recorded, in which a longer completion time and more error will indicate poorer outcome. Construct validity of the Stroop Test in the TBI population has been published.
Trail-Making Test (TMT A and B)
Time frame: Change from baseline to post-intervention within 1 week
Trail-Making Test (TMT A and B) will be used to measure sustained attention, sequencing, mental flexibility, and visual tracking. TMT-A requires the individual to link in an ascending order a series of 25 numbered circles distributed randomly on a test paper as quickly as possible. TMT-B is similar, although it requires the individual to link switching alternatively between a set of numbers (1-13) and a set of letters (A-L) in an ascending order (1-A-2-B-3-C...). The Time and the amount of needed reminders to complete TMT A and B will be calculated, in which a longer completion time and more error will indicate poorer outcome. This instrument was validated in healthy people, patients with head injury, vascular disorders, and other diverse populations.
Montreal Cognitive Assessment (MoCA)
Time frame: Change from baseline to post-intervention within 1 week
Montreal Cognitive Assessment (MoCA) is a clinician-reported measure consisting of cognition domains such as: visuospatial skills, executive functions, attention, concentration, calculation, language, abstraction, memory, and orientation. The summary score ranges from 0-30 points with higher scores indicating better cognitive function.
59 secondary outcomes
Activity Measure for Post-Acute Care (AMPAC) Outpatient Short Forms
Time frame: Change from baseline to post-intervention within 1 week
Activity Measure for Post-Acute Care (AMPAC) Outpatient Short Forms
Time frame: Change from post-intervention to 3 month follow-up, within 2 weeks
Activity Measure for Post-Acute Care (AMPAC) Outpatient Short Forms
Time frame: Change from 3 month to 6 month follow-up, within 2 weeks
Activity Measure for Post-Acute Care (AMPAC) Outpatient Short Forms
Time frame: Change from 6 month to 12 month follow-up, within 2 weeks
Healing encounters and attitudes list positive outlook questionnaire short form (HEAL-PO)
Time frame: Change from baseline to post-intervention within 1 week
Healing encounters and attitudes list positive outlook questionnaire short form (HEAL-PO)
Time frame: Change from post-intervention to 3 month follow-up, within 2 weeks
Healing encounters and attitudes list positive outlook questionnaire short form (HEAL-PO)
Time frame: Change from 3 month to 6 month follow-up, within 2 weeks
Healing encounters and attitudes list positive outlook questionnaire short form (HEAL-PO)
Time frame: Change from 6 month to 12 month follow-up, within 2 weeks
General Self Efficacy Scale (GSCS)
Time frame: Change from baseline to post-intervention within 1 week
General Self Efficacy Scale (GSCS)
Time frame: Change from post-intervention to 3 month follow-up, within 2 weeks
General Self Efficacy Scale (GSCS)
Time frame: Change from 3 month to 6 month follow-up, within 2 weeks
General Self Efficacy Scale (GSCS)
Time frame: Change from 6 month to 12 month follow-up, within 2 weeks
Canadian Occupational Performance Measure (COPM)
Time frame: Change from baseline to post-intervention within 1 week
Canadian Occupational Performance Measure (COPM)
Time frame: Change from post-intervention to 3 month follow-up, within 2 weeks
Canadian Occupational Performance Measure (COPM)
Time frame: Change from 3 month to 6 month follow-up, within 2 weeks
Canadian Occupational Performance Measure (COPM)
Time frame: Change from 6 month to 12 month follow-up, within 2 weeks
Stroop Test
Time frame: Change from post-intervention to 3 month follow-up, within 2 weeks
Stroop Test
Time frame: Change from 3 month to 6 month follow-up, within 2 weeks
Stroop Test
Time frame: Change from 6 month to 12 month follow-up, within 2 weeks
Trail-Making Test (TMT A and B)
Time frame: Change from post-intervention to 3 month follow-up, within 2 weeks
Trail-Making Test (TMT A and B)
Time frame: Change from 3 month to 6 month follow-up, within 2 weeks
Trail-Making Test (TMT A and B)
Time frame: Change from 6 month to 12 month follow-up, within 2 weeks
National Institutes of Health Stroke scale (NIHSS)
Time frame: Change from baseline to post-intervention within 1 week
National Institutes of Health Stroke scale (NIHSS)
Time frame: Change from post-intervention to 3 month follow-up, within 2 weeks
National Institutes of Health Stroke scale (NIHSS)
Time frame: Change from 3 month to 6 month follow-up, within 2 weeks
National Institutes of Health Stroke scale (NIHSS)
Time frame: Change from 6 month to 12 month follow-up, within 2 weeks
Rancho Los Amigos Scale-Revised (RLAS-R)
Time frame: Change from baseline to post-intervention within 1 week
Rancho Los Amigos Scale-Revised (RLAS-R)
Time frame: Change from post-intervention to 3 month follow-up, within 2 weeks
Rancho Los Amigos Scale-Revised (RLAS-R)
Time frame: Change from 3 month to 6 month follow-up, within 2 weeks
Rancho Los Amigos Scale-Revised (RLAS-R)
Time frame: Change from 6 month to 12 month follow-up, within 2 weeks
Modified Rankin Scale (mRS)
Time frame: Change from baseline to post-intervention within 1 week
Modified Rankin Scale (mRS)
Time frame: Change from post-intervention to 3 month follow-up, within 2 weeks
Modified Rankin Scale (mRS)
Time frame: Change from 3 month to 6 month follow-up, within 2 weeks
Modified Rankin Scale (mRS)
Time frame: Change from 6 month to 12 month follow-up, within 2 weeks
Euro-QoL-5-Dimension (EQ-5D)
Time frame: Change from baseline to post-intervention within 1 week
Euro-QoL-5-Dimension (EQ-5D)
Time frame: Change from post-intervention to 3 month follow-up, within 2 weeks
Euro-QoL-5-Dimension (EQ-5D)
Time frame: Change from 3 month to 6 month follow-up, within 2 weeks
Euro-QoL-5-Dimension (EQ-5D)
Time frame: Change from 6 month to 12 month follow-up, within 2 weeks
Qualitative data
Time frame: After intervention, an average of 2 month
Participation Measure- 3 Domains, 4 Dimensions (PM-3D4D)
Time frame: Change from baseline to post-intervention within 1 week
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 10 Apr 2024.
- Individual participant dataSharing planned: No. The IPD is not planned to be shared.
Related trials for Cognitive Impairment
Enrolling by invitationPhase 2
Tau PET Outcomes With Anti-amyloid Immunotherapies
Cognitive Impairment, Mild, Dementia, Mild
Active, not recruiting
Primary Care Detection of Cognitive Impairment Leveraging Health & Consumer Technologies in Underserved Communities: The MyCog Trial
Dementia, Cognitive Impairment
RecruitingPhase 1
PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI)
Alzheimer s Disease, Mild Cognitive Impairment
Active, not recruitingPhase 4
A Study Testing How Well the Drug Extract of Ginkgo Biloba Leaves Tablets Works for People With Memory or Thinking Problems After a Stroke When Added to Standard Treatment
Ischemic Stroke Hospitalized, Impairment, Cognitive
Not yet recruitingObservational study
Perception of Action Opportunities for Obstacle Crossing in Parkinson's Disease
PARKINSON DISEASE (Disorder), Older Adults (65-85 Years)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Feng-Hang Chang principal investigator
Taipei Medical University
3 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Strategy Training in people with Cognitive Impairment and Stroke, run by Taipei Medical University at 3 sites in Taiwan.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 10 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 3 sites in Taiwan. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Stroop Test (time frame: Change from baseline to post-intervention within 1 week). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 10 Apr 2024.